PTGX
Protagonist Therapeutics Inc
Halal Rating :
Last Price
$36.82
Last updated:
Market Cap
-
7D Change
-0.86%
1 Year Change
47.28%
Company Overview
Industries
Exchange
Next Earnings Date
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company that focuses on discovering and developing peptide-based therapeutic drugs to address significant unmet medical needs. The company's primary focus is on developing novel peptide-based drugs for blood disorders, autoimmune diseases, and other serious medical conditions.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $4.67m | $46.13m | - | - | 0.00% | 0.00% |
| June 30, 2024 | $4.17m | $42.96m | - | - | 0.00% | 0.00% |
| March 31, 2024 | $254.95m | $48.64m | - | - | 0.00% | 0.00% |
Company Impact
Help us evaluate Protagonist Therapeutics Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.